Crossmark

Heparin-binding epidermal growth factor contributes to COPD disease severity by modulating airway fibrosis and pulmonary epithelial–mesenchymal transition

Crossref DOI link: https://doi.org/10.1038/s41374-018-0049-0

Published Print: 2018-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lai, Tianwen

Li, Yanyu

Chen, Min

Pan, Guihai

Wen, Xiaoxia

Mai, Zongjiong

Yuan, Yalian

Lv, Yingying

Lv, Quanchao

Cen, Ruilian

Yi, Huajuan

Wen, Mengling

Li, Dongming

Wu, Bin

Wu, Dong

Cao, Chao
License Information

Text and Data Mining valid from 2018-09-01

Text and Data Mining valid from 2018-09-01

Version of Record valid from 2023-01-11
More Information

This article is maintained by: Elsevier

Article Title: Heparin-binding epidermal growth factor contributes to COPD disease severity by modulating airway fibrosis and pulmonary epithelial–mesenchymal transition

Journal Title: Laboratory Investigation

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41374-018-0049-0

Content Type: article

Copyright: © 2018 United States & Canadian Academy of Pathology.

Document is current

Any future updates will be listed below